Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
CancerPain
Interventions
DRUG

Fentanyl sublingual spray

Fentanyl sublingual spray in doses of 100, 200, 400, 600, 800, 1200, and 1600 µg

Trial Locations (52)

Unknown

Huntsville

Winfield

Glendale

Scottsdale

Laguna Hills

Loma Linda

Los Gatos

San Mateo

Bradenton

Lake Worth

Miami

Winter Park

Newnan

Chicago

Skokie

Zion

Elkhart

Bethesda

Southfield

Edina

Jefferson City

Great Falls

Kalispell

Missoula

Voorhees Township

Flat Rock

Winston-Salem

Canton

Dayton

Eugene

Altoona

Danville

Lemoyne

Kingsport

Bellaire

Dallas

Fort Worth

Port Sam Houston

Tacoma

Appleton

Oakville

Montreal

Québec

Saskatoon

Ahmedabad

Bangalore

Bhopal

Hyderabad

Jaipur

Mumbai

Nashik

Pune

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY